Skip to content

Clinical Application Research of 18F/68Ga-T1 PET In Inflammatory Bowel Disease

Clinical Application Research of 18F/68Ga-T1 PET In Inflammatory Bowel Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121333
Enrollment
Unknown
Registered
2026-03-30
Start date
2026-03-31
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To evaluate the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 18F/68Ga T1-PET/CT in assessing the activity and fibrosis of inflammatory bowel disease, with endoscopy as the gold standard.

Interventions

Gold Standard:1. Endoscopic examination (the active stage is defined as a Mayo score of >= 2 points)
2. Mucosal biopsy
Index test:18F/68Ga-T1 PET

Sponsors

SHANGHAI TENTH PEOPLES HOSPITAL
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old; 2.Voluntary signing of informed consent; 3. Plan to receive biological agent treatment (such as anti-TNF-a).

Exclusion criteria

Exclusion criteria: 1. Pregnancy/lactation; 2. Severe heart, liver or kidney failure (eGFR < 30 ml/min); 3. Metal implants ; 4. Claustrophobia; 5. Recent (less than 4 weeks) use of immunosuppressants.

Design outcomes

Primary

MeasureTime frame
Specificity;Sensitivity;Accuracy;

Secondary

MeasureTime frame
Positive Predictive Value;Negative Predictive Value;

Countries

China

Contacts

Public ContactChao Ma

SHANGHAI TENTH PEOPLES HOSPITAL

ponymachao@163.com+86 187 2128 8964

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026